The management of resistant HTN involves maximizing lifestyle changes, using long-acting thiazide diuretics (chlorthalidone or indapamide), adding MR antagonist (spironolactone or eplerenone), and gradually introducing additional antihypertensive medications with different mechanisms of action if the BP remains high [156,157]. This evidence concerns the gene NR3C2 and hypertensive disorder.